Disease: Bullous pemphigoid
- <em>Staphylococcus aureus</em> proteases trigger eosinophil-mediated skin inflammation
- A case of anti-laminin gamma1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration
- A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration
- A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- A Case Report of the Ascending Colon Cancer with Bullous Pemphigoid
- A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID-19 vaccination: The good, the bad, and the ugly
- A Novel Strategy for the Discovery of Drug Targets: Integrating Clinical Evidence with Molecular Studies
- A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2
- Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update
- An Urticarial and Acral Manifestation of Bullous Pemphigoid After Vildagliptin Therapy: A Case Report
- Analysis of a Combination Therapy Protocol for the Treatment of Oral Mucous Membrane Pemphigoid: A Retrospective Case Series Study
- Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity
- Anti-laminin 332 antibodies in graft-versus-host disease-associated bullous pemphigoid after allogeneic peripheral blood stem cell transplantation
- Atezolizumab-Induced Type 1 Diabetic Ketoacidosis in a Patient With Small Cell Lung Cancer and Pre-existing Type 2 Diabetes Mellitus
- Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study
- Bendamustine as a Cause of Drug-Associated Bullous Pemphigoid-A Rare Side Effect
- Beyond guidelines: the high-dose challenge in severe bullous pemphigoid-a hospital perspective
- Bullous dermatomyositis with anti-NPX2 antibodies, associated with breast cancer
- Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis
- Bullous pemphigoid and lichen planus pemphigoides in monozygotic twins with a long-standing history of psoriasis
- Bullous Pemphigoid Associated With the Use of Sacubitril/Valsartan: A Case Report and Literature Review
- Bullous Pemphigoid Causing Successive Emergency Department Visits
- Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection
- Bullous pemphigoid, malignant acanthosis nigricans, and erysipeloid carcinoma in a woman with gastric adenocarcinoma
- Causal association between psoriasis vulgaris and bullous pemphigoid: a two-sample bidirectional Mendelian randomization study
- Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid
- Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review
- Claudin-4 Upregulation in Acantholytic and Autoimmune-Mediated Bullous Disorders
- Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study
- Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid
- Cutaneous blisters mimicking bullous pemphigoid
- Dapsone-Induced Methemoglobinemia Presenting Concomitantly With COVID-19 Pneumonia and Pulmonary Embolism: A Case Report
- Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
- Dermatological side effects of dipeptidyl Peptidase-4 inhibitors in diabetes management: a comprehensive review
- Diagnostic challenges of superficial mucoceles: An update
- Diagnostic Utility of Direct Immunofluorescence on Paraffin-Embedded Skin Biopsy Samples for the Diagnosis of Autoimmune Vesiculobullous Lesions
- Differentiation of keratinocytes or exposure to type 2 cytokines diminishes <em>S. aureus</em> internalization
- DPP4-Inhibitor-assoziiertes bulloses Pemphigoid mit Osophagusbeteiligung: Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid
- Effect of clarithromycin in a case of infantile bullous pemphigoid
- Efficacy of Omalizumab for the treatment of Bullous Pemphigoid. Spanish multicenter real-world experience
- Epidemiological Study of Autoimmune Bullous Dermatoses in Northeastern Romania
- Epidemiology and Co-Morbidities of Mucous Membrane Pemphigoid: A National Cohort Study
- Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study
- Epidermolysis Bullosa Acquisita
- Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom: Successful treatment of checkpoint inhibitor‐associated bullous pemphigoid with dupilumab in a patient with angiosarcoma
- Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid
- Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid: A case report
- Evaluation of the relationship between serum eosinophil and D-dimer levels and demographic and clinical characteristics in bullous pemphigoid patients
- Evaluation of the Status of Patients with Autoimmune Bullous Diseases (Pemphigus and Bullous Pemphigoids) in Dermatology Clinics of Mashhad University of Medical Sciences During the COVID-19 Pandemic Using Telemedicine
- Expression of Serum Anti-BP180/230 Antibodies in Bullous Pemphigoid Patients Combined with Nervous System Diseases and Relevant Factor Analysis
- Fiberoptic endoscopic assessment of dysphagia in a patient with cutaneous and oropharyngeal blisters
- Gingival Manifestations in Oral Chronic Autoimmune Bullous Diseases: A Retrospective Study
- HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment
- Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
- IgE anti-BP180 NC16A autoantibody in both serum and blister fluid samples does not correlate with disease activity of bullous pemphigoid
- IgM-mediated epidermolysis bullosa acquisita
- Integrating Osteopathic Principles for Enhanced Dermatological Outcomes: A Literature Review
- Laryngeal Manifestations of Bullous Pemphigoid: Case Report and Review of the Literature
- Lichen Planus Pemphigoides Induced by Camrelizumab in Combination With Lenvatinib
- Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review
- Linear IgA bullous dermatosis associated with immunotherapy
- Low pH condition impairs BP-IgG binding to the basement membrane zone
- Management of pemphigoid vegetans with mycophenolate mofetil: A case report
- Navigating through the challenges of bullous pemphigoid and breast cancer in the elderly
- New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies
- Nonbullous pemphigoid mimicking arthropod bite reactions in a patient with previously controlled classic bullous pemphigoid
- Omalizumab used to treat bullous pemphigoid resistant to other treatments
- Oral mucous membrane pemphigoid: updates in diagnosis and management
- Paraneoplastic pemphigus with underlying Castleman's disease in a 16-year-old girl
- PD-1/PD-L1 Checkpoint Inhibition Associated Bullous Pemphigoid: A Propensity Matched Retrospective Cohort Study
- Pemphigoid and atopy: A case-control study in the All of Us database
- Pemphigoid ohne Schleimhautbeteiligung, mit IgG‐Antikörpern gegen die β3‐Untereinheit von Laminin‐332: Pemphigoid without mucous involvement showing IgG antibodies to the β3 subunit of laminin‐332
- Pemphigoid without mucous involvement showing IgG antibodies to the beta3 subunit of laminin-332
- Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound
- Potential Indications of Dupilumab in Th-2 Inflammatory Disease
- Presence of immunoglobulin E-expressing antibody-secreting cells in the dermis close to bullous pemphigoid lesions
- Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice
- Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study
- Risk and determinants of herpes zoster in bullous pemphigoid: a large-scale population-based study
- Role of C4d immunohistochemical marker in the diagnosis of bullous pemphigoid: A cross-sectional study
- Single-cell profiling unveils the inflammatory heterogeneity within cutaneous lesions of bullous pemphigoid
- Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid
- Spatial transcriptomics of pemphigus vulgaris and bullous pemphigoid: Insights into pathogenesis and therapy on bullous formation
- Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT
- Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma
- Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein
- Terbinafine induced bullous pemphigoid
- The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience
- The Koebner Phenomenon in Bullous Pemphigoid
- The management of pemphigus vulgaris and mucous membrane pemphigoid in a joint oral medicine and dermatology clinic: a five-year narrative review
- The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls
- The Prevalence of Clinically Undiagnosed Depression in Patients With Autoimmune Bullous Diseases Seen at Inkosi Albert Luthuli Central Hospital, Durban, South Africa
- The role of COVID-19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid
- The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series
- The Syk Inhibitor Entospletinib Abolishes Dermal-Epidermal Separation in a Fully Human Ex Vivo Model of Bullous Pemphigoid
- Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis
- U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study
- Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study
- Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review